| Financial Year |
March 31 2022 |
| Monetary Funds |
6,749,122,103.09 |
| Held-for-trading Financial Assets |
70,920,064.38 |
| Notes Receivable |
1,451,570,667.95 |
| Accounts Receivable |
874,423,772.06 |
| Advances to Suppliers |
4,333,139,072.37 |
| Other Receivables |
12,477,691.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,018,757,094.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,963,200.00 |
| Other Current Assets |
1,742,639,399.95 |
| Total Current Assets |
19,313,642,782.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,139,834.07 |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,919,524.27 |
| Fixed Assetes |
1,891,540,151.64 |
| Under-construction Projects |
303,620,897.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,157,879,848.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
47,683,867.77 |
| Other Non-Current Assets |
63,519,477.47 |
| Sub-Total of Non-Current Assets |
9,836,443,239.03 |
| Total Assets |
29,150,086,021.60 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,311,766,222.70 |
| Accounts Payable |
2,807,382,485.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
65,793,436.87 |
| Taxes Payable |
61,812,441.61 |
| Interest Payable |
-- |
| Dividend Payable |
188,800.00 |
| Other payables |
135,765,611.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,642,717.04 |
| Other Current Liabilities |
259,490,314.49 |
| Sub-Total of Current Liabilities |
18,011,456,589.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
406,635,188.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
415,555.60 |
| Deferred Income Tax Liabilities |
138,009.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
501,946,342.98 |
| Total Liabilities |
18,513,402,932.77 |
| Paid-In Capital(Or Share Stock) |
1,704,251,817.00 |
| Capital Surplus |
4,391,231,811.67 |
| Surplus Reserve |
375,989,476.55 |
| LESS:Treasury Stock |
70,953,540.00 |
| Undistributed Profits |
4,096,434,645.52 |
| Minority Stockholder's Interest |
48,864,833.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,587,818,255.16 |
| Owner's Equity（Stockholder's Equity） |
10,636,683,088.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,150,086,021.60 |
